PURPOSE & INTRODUCTION

Slides:



Advertisements
Similar presentations
Golan.O, Sperber.F, Shalmon.A, Weinstein.I, Gat.A
Advertisements

BREAST CANCER CASE STUDY FRAZER BELL STUDENT BMS BSc APPLIED BIOMEDICAL SCIENCE.
Breast Cancer Tumor Board Chair Harold Burstein, MD, PhD Faculty Jennifer Bellon, MD Mehra Golshan, MD.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Method for Determining Apparent Diffusion Coefficient Values for Cerebral Lesions from Diffusion Weighted Magnetic Resonance Imaging Examinations T.H.
Role of MRI in Breast Cancer Angela Kong Princess Margaret Hospital.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.
2 years later, she noticed multiple cm
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
The 70 gene Mammaprint ™ signature: a comparison with traditional clinico-pathological parameters. Patrizia Querzoli 1, Massimo Pedriali 1, Gardenia Munerato.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
The Role of Ultrasound of the Regional Nodal Basins in Staging Patients with Triple Negative Breast Cancer: Implications for Local-Regional Treatment Simona.
NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Pathology.
Should liver metastases of breast cancer be biopsied to improve treatment choice? M. A. Locatelli, G. Curigliano, L. Fumagalli, V. Bagnardi, G. Aurilio,
NEOPLASIA CASES. CASE 1 A 20 year old female presented with a round mobile breast lump. She has no family history of breast cancer Question : What test.
Characteristic Dynamic Enhancement Pattern of MR imaging for Malignant Thyroid Tumor XIX Symposium Neuroradiologicum Division of Head & Neck radiology.
Breast Cancer »Breast cancer is a malignant tumor that starts in the cells of the breast. »The disease occurs almost entirely in women,but men can get.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Radiological-histological size correlation in triple-negative breast cancer (TNBC) Abstract # 8254 C Thibault 1, M Gosset 2, F Chamming’s 3, M-A Lefrere-Belda.
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.
University of Pennsylvania Department of Orthopaedic Surgery Joseph King, Eileen Crawford, Abass Alavi, Arthur Staddon, Lee Hartner, Richard Lackman and.
A prospective study of PET/CT in initial staging of small-cell lung cancer : comparison with CT, bone scintigraphy and bone marrow analysis B. M. Fischer1,
Investigations of Breast Cancer -by preetam goswami 8th semester,unit-1.
TMIST A Breast Cancer Screening Trial
Correlation of tumor blood volume and apparent diffusion coefficient values with the prognostic parameters of head and neck squamous cell carcinoma Abdel.
Advanced loco regional Regional breast cancer
Number of brain metastasis
Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,
Underwriting Breast Cancer
Ari Brooks, MD Cancer Surgeon, Big Data End User
Nurdianah HF, Nizuwan A, Muhamad Yusri M
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
Operative Approach and
Zehra Nihal Dolgun, Ahmet Salih Altintas, Cihan Inan, Petek Balkanli
Basile Pache, Antonia Digklia*, Nicolas Demartines, Maurice Matter.
RADIOLOGICAL AND HISTOPATHOLOGICAL CHARACTERISTIC FEATURES OF BREAST CANCER PATIENTS IN HOSPITAL SERDANG Lim SN.1, Nuratika B.1, Suraini M.S.2, Norafida.
 [P1]Can you put in the numbers here for specificity and NPV
BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.
Case scenario- Breast Lump
Marcelo Calil Instituto Brasileiro de Controle do Câncer
Table (1):Relation between lymph node and molecular subtypes.
But how to treat those with positive SLNB? Results and Discussion
Assessing neoadjuvant chemotherapy (NAC) response in patients with breast cancer using PEM and DCE-MRI: Pilot data Kirti Kulkarni MD, Daniel Appelbaum.
Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging  Doenja M.J. Lambregts,
Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT
Predict “invasive component” within ductal carcinoma in situ – the breast MRI features and clinicopathologic factors ? Hung-Wen Lai, MD, PhD1,4, Dar-Ren.
VALUES OF ELASTOGRAPHY IN DIAGNOSIS OF THYROID CANCER
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Metastatic Breast cancer
Current Status of Breast Ultrasound
سرطان الثدي Breast Cancer
Dr T P E Wells 13 July 2018 Breast SSG Bath
The Role of Modern Molecular Imaging Techniques in Gastroenterology
Treatment Overview: The Multidisciplinary Team
Handling and Evaluation of Breast Cancer Biopsy
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Tumor Characteristics and Molecular Subtypes in Breast Cancer Screening with Digital Breast Tomosynthesis: The Malmö Breast Tomosynthesis Screening Trial.
Presentation transcript:

PURPOSE & INTRODUCTION Comparison between 18F-FDG uptake patern and apparent diffusion coefficient value obtained from diffusion-weighted magnetic resonance imaging on the detection of primary tumour and axillary metastases in breast carcinoma   Aynur Ozen1, Tarik Sayin2, Ozgul Ekmekcioglu 1, Serdar Altinay3, Eylem Bastug 1, Ali Muhammedoglu 3, Atilla Celik4, Ramazan Albayrak2 Departments of Nuclear Medicine1, Radiology2, Pathology3 and General Surgery4, Bagcilar Training and Research Hospital, Istanbul, Turkey ANNUAL CONGRESS OF THE EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE OCTOBER 10-14, 2015 HAMBURG/GERMANY BAĞCILAR TRAINING AND RESEARCH HOSPITAL ISTANBUL/TURKEY Figure PURPOSE & INTRODUCTION Breast carcinoma (BC) is the most common type of cancer in female population1. Breast magnetic resonance maging (MRI) detects increased blood flow and tissue resolution in order to diagnose cancer, thus, being more sensitive and accurate than mammography and ultrasonography2. When breast MRI findings are suspicious, diffusion-weighted magnetic resonance imaging (dw-MRI) provides additional information about microstructural characteristics of tissue and it is increasingly performed in the evaluation of tumours3. Furthermore, the apparent diffusion coefficient (ADC) value obtained from dw-MRI was useful in differentiating between benign and malignant breast lesions4-8. Our objective was to compare SUVmax patern in 18F-FDG PET/CT and ADC value of dw-MRI for the detection of primary tumour and axillary lymph node (ALN) metastases of BC. SUBJECTS & METHODS This retrospective study included 42 female patients (mean age, 51,3012,26 years; age range, 29-78 years) with BC. Thirty-eight patients had invasive ductal carcinoma, one of them with sarcomatoid differentiation, 1 invasive lobular carcinoma, 1 mixed type, 1 mucinous and 1 medullar BC. After pre-operative staging with 18F-FDG PET/CT and dw-MRI, mastectomy or breast conserving surgery with ALN disection or sentinel lymph node biopsy was performed. For histopathologic evaluation, Modified Bloom Richardson grading system was used. Furthermore, oestrogen (ER), progesteron (PR) receptor expression and Her-2/neu statuses were determined. SUVmax was measured from primary tumour, metastatic ALN, the normal parenchymas of breast, lung and liver. Also, ADC was measured from breast tumour and metastatic ALN. SUVmax ratios was calculated following as: TumourSUVmax/breastSUVmax, TumourSUVmax/lungSUVmax, TumourSUVmax/liverSUVmax. (a) Transaxial PET/CT images in supine position, (b) images at prone position obtained shortly after supine position images for accurate localization of primary tumour and (c) ADC map in diffusion weighted imaging display, in a 40 years old woman with IDBC and 2.5cm tumour size, grade 3, ER-PR positive, 1+ Her2/neu status in right breast. ROIs are shown on a and b for measuring SUVmax, and on c for measuring the mean ADC value. DISCUSSION & CONCLUSION Our study suggested that a) the primary lesions detection rate of both 18F-FDG PET/CT and dw-MRI was high, 95.3%. b) Both modalities had the same specificity for the detection of ALN metastases, but the 18F-FDG PET/CT scan had lower sensitivity than dw-MRI and c) SUVmax and SUVmax ratios were more compatible with pathological parameters than ADC value. These two imaging modalities might play a supplemantary role in the detection of BC and ALN metastases. REFERENCES Carlson RW, Allred DC, Anderson BO, et al. NCCN Breast Cancer Clinical Practice Guidelines Panel: Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009;7:122-192. Biglia N, Mariani L, Sgro L, et al. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment. Endocr Relat Cancer 2007;14:549-567. Koh DM, Takahara T, Imai Y, et al. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007;6:211-224. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16:172-178. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7:23-29. Kinoshita T, Yashiro N, Ihara N, et al. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002;26:1042-1046. Kuroki Y, Nasu K, Kuroki S, et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004;3:79-85. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005;4:35-42. RESULTS Results showed that the primary lesion detection rate for PET/CT and dw-MRI was 95.3%. The 18F-FDG PET/CT scan had lower sensitivity in detecting of ALN metastases than dw-MRI, while their specificities were equal. Higher SUVmax and/or SUVmax ratios correlated with stage T2 tumours, with histologic grade 3, and with negative ER and PR receptor status. There was no correlation between ADC and SUVmax or SUVmax ratios both primary tumour and metastatic axillary lymph node.